- Q1. What is the business of Sahajanand Medical Technologies Limited ?It develops and manufactures advanced cardiovascular medical devices like coronary stents, balloons, valves and occluders used for vascular intervention and structural heart treatments globally.
- Q2. Why is the company raising funds via IPO?The IPO is mainly an Offer For Sale (OFS) to enable existing investors to unlock value and list the company publicly.
- Q3. What is the size of the issue and where will it list?The issue size of the IPO comprises entirely an OFS of ~2.76 Cr equity shares. It will be listed on BSE and NSE platform.
- Q4. What are the key risks to an investor?Key risks include dependence on cardiovascular products, strict regulatory approvals in medical devices, pricing controls on stents, and strong competition from global medical technology companies.
- Q5. What are the potential upsides?The company benefits from strong R&D, global presence in 70+ countries, growing demand for minimally invasive cardiac treatments, and increasing adoption of advanced medical devices.
- Q6. How to apply for the IPO?Investors can apply for the IPO through ASBA via net banking or using UPI through registered stock brokers once the IPO opens for subscription.
- Toggle TitleToggle Content
Upcoming
Sahajanand Medical Technologies Limited
0
IPO Score
0
*Score varies on actual price
Sahajanand Medical Technologies Limited is an R&D-driven medical device manufacturer specializing in advanced cardiovascular devices such as coronary stents, balloons, and structural heart solutions. The company focuses on vascular intervention and structural heart treatments, with its products used in hospitals across more than 70 countries. The company has filed its draft red herring prospectus with the Securities and Exchange Board of India (SEBI) to initiate an Initial Public Offering (IPO) entirely of offer-for-sale (OFS) of up to ~2.76 Cr equity shares by existing investors.
Sahajanand Medical Technologies Limited was incorporated on 2001 & currently Mr. Bhargav Dhirajlal Kotadia serves as the Managing Director & Chief Executive Officer (CEO) of the company.
It develops and manufactures cardiovascular medical devices, mainly coronary stents, balloon catheters, trans-catheter aortic valves (TAVI) and occluders used in vascular and structural heart treatments.It’s supplies its products to 75+ countries worldwide, supplying hospitals and cardiology centres globally.The company holds ~25% market share in India’s Drug-Eluting Stent (DES) segment by sales volume.
Subscription date to apply for Sahajanand Medical Technologies Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
Year |
2025 |
|---|---|
Networth
|
₹ 545.23 Cr
|
Revenue
|
₹ 1024.87 Cr
|
EBITDA
|
₹ 128.02 Cr
|
PAT
|
₹ 25.15 Cr
|
EBITDA Margin
|
~12.49%
|
PAT Margin
|
~2.45%
|
Face Value
|
Rs.1 per Equity Share
|
IPO Important Dates
# |
Date |
|---|---|
Open Date
|
TBA
|
Close Date
|
TBA
|
Anchor Investor Bidding
|
TBA
|
Allotment Date
|
TBA
|
Refunds& Demat Credit
|
TBA
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
Purpose |
Amount |
|---|---|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
General Corporate Purpose
|
Balance
|
Financial Data
# |
2023 |
2024 |
2025 |
|---|---|---|---|
Revenue (₹ Cr)
|
₹ 795.5
|
₹ 901.6
|
₹ 1,024.9
|
PAT (₹ Cr)
|
₹ 11.9
|
₹ -7.4
|
₹ 25.2
|
Asset (₹ Cr)
|
₹ 911.6
|
₹ 970.6
|
₹ 1,094.9
|
Net Worth (₹ Cr)
|
₹ 539.2
|
₹ 526.3
|
₹ 545.2
|
IPO Grey Market Premium
Date |
IPO Price |
IPO GMP |
Profit Per Lot |
|---|---|---|---|
23-Aug
|
₹ –
|
₹ –
|
₹ –
|
22-Aug
|
₹ –
|
₹ –
|
₹ –
|
21-Aug
|
₹ –
|
₹ –
|
₹ –
|
20-Aug
|
₹ –
|
₹ –
|
₹ –
|
19-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
Promoters |
% Shares |
|---|---|
Shree Hari Trust
|
~ 36.79 %
|
Dhirajkumar Savjibhai Vasoya
|
~ 4.03 %
|
Sahajanand Technologies Private Limited
|
~ 0.06 %
|
Jitendra Vallabhbhai Kotadia
|
~ 0.03 %
|
-
|
-
|
-
|
-
|
Lot Size details
Application Type |
Lot Size |
No. of Lot |
No. of Shares |
Investment Amount |
|---|---|---|---|---|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
ROE |
00 |
|---|---|
ROCE
|
00
|
RoNW
|
00
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
Checkout more upcoming IPO's
SBI Funds Management Limited
SBI Funds Management Limited is a leading asset management company engaged in managing mutual funds...
Read More
OnEMI Technology Solutions Limited
OnEMI Technology Solutions Limited is a technology-enabled digital lending company that operates the Kissht platform,...
Read More
Supreet Chemicals Limited
Supreet Chemicals Limited is a specialty chemical intermediates manufacturer serving industries such as textiles, pharmaceuticals,...
Read More
Executive Centre India Limited
Executive Centre India Limited provides premium flexible workspace and serviced office solutions by leasing Grade-A...
Read MoreSahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited is an R&D-driven medical device manufacturer specializing in advanced cardiovascular devices...
Read More